Natalizumab-related PML in multiple sclerosis: a case report

被引：0
|
作者：
Papadopoulos, D.
Plafadeli, A.
Zafeiropoulou, E.
Kontogeorgi, E.
Alexopoulos, H.
Veretzioti, A.
Zisimopoulou, V.
Dalakas, M. C.
Tavernarakis, A.
机构：
[1] Evangelismos Gen Hosp, Athens, Greece
[2] Univ Athens, Athens, Greece
来源：
JOURNAL OF NEUROLOGY | 2012年 / 259卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S109 / S110
页数：2
相关论文
共 50 条
  • [1] Management of natalizumab-related PML: a different approach
    Cordioli, C.
    Costanzi, C.
    De Rossi, N.
    Rasia, S.
    Capra, R.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 462 - 462
  • [2] Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients
    Cinzia Cordioli
    Nicola De Rossi
    Sarah Rasia
    Giovanni Lodoli
    Ruggero Capra
    Neurological Sciences, 2015, 36 : 489 - 491
  • [3] Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis
    Foley, Robert W.
    Tagg, Nathan T.
    Schindler, Matthew K.
    Fenton, Kaylan M.
    Reich, Daniel S.
    Cortese, Irene
    Mowry, Ellen M.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (10) : 1424 - 1427
  • [4] Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients
    Cordioli, Cinzia
    De Rossi, Nicola
    Rasia, Sarah
    Lodoli, Giovanni
    Capra, Ruggero
    NEUROLOGICAL SCIENCES, 2015, 36 (03) : 489 - 491
  • [5] Rituximab Treatment of Highly Active Multiple Sclerosis (MS) After Natalizumab-Related Progressive Multifocal Leukoencephalopathy (PML)
    Cordioli, Cinzia
    De Rossi, Nicola
    Rasia, Sarah
    Santuccio, Giuseppe
    Capra, Ruggero
    NEUROLOGY, 2016, 86
  • [6] Review reveals no new cases of natalizumab-related PML
    Reactions Weekly, 2006, 1092 (1) : 5 - 5
  • [7] Case report of natalizumab-related ocular cicatricial pemphigoid
    Gerbo, Michael L.
    Powers, Roxann L.
    DERMATOLOGIC THERAPY, 2021, 34 (01)
  • [8] Extended dosing interval reduces risk of natalizumab-related PML
    Reactions Weekly, 2019, 1772 (1) : 9 - 9
  • [9] Minimal supportive treatment in natalizumab-related PML in a MS patient
    Lalive, Patrice H.
    Bridel, Claire
    Ferfoglia, Ruxandra Iancu
    Kaiser, Laurent
    Du Pasquier, Renaud
    Barkhof, Frederik
    Haller, Sven
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (03): : 354 - U184
  • [10] Natalizumab-Related Progressive Multifocal Leukoencephalopathy (PML) in Multiple Sclerosis (MS) Italian Patients: Course, Outcome and Follow-Up
    De Rossi, Nicola
    Cardinli, Cinzia
    Amato, Maria Pia
    Gerevini, Simonetta
    Clerico, Marinella
    Deotto, Luciano
    De Riz, Milena Alessandra
    Scarpazza, Cristina
    Fusco, Maria Letizia
    Ghezzi, Angelo
    Grimaldi, Luigi Maria
    Grimaldi, Luigi Maria
    Lugaresi, Alessandra
    Moiola, Lucia
    Perrone, Patrizia Susanna Mar
    Prosperini, Luca
    Rezzonico, Monica
    Rovaris, Marco
    Salemi, Giuseppe
    Salvetti, Marco
    Santuccio, Giuseppe
    Tortorella, Carla
    Capra, Ruggero
    NEUROLOGY, 2016, 86
12345